Financial - Capital Markets
Compare Stocks
5 / 10Stock Comparison
MDBH vs TPVG vs HTGC vs GAIN vs ARCC
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
MDBH vs TPVG vs HTGC vs GAIN vs ARCC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Capital Markets | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $18M | $243M | $3.07B | $657M | $13.61B |
| Revenue (TTM) | $2M | $97M | $547M | $90M | $3.15B |
| Net Income (TTM) | $11M | $-12M | $289M | $130M | $1.15B |
| Gross Margin | -8.0% | 83.5% | 87.2% | 68.6% | 75.7% |
| Operating Margin | -12.9% | 77.9% | 66.7% | 72.7% | 69.7% |
| Forward P/E | 1.4x | 6.5x | 8.4x | 40.7x | 9.9x |
| Total Debt | $712K | $469M | $2.30B | $456M | $15.99B |
| Cash & Equiv. | $20M | $20M | $57M | $14M | $924M |
MDBH vs TPVG vs HTGC vs GAIN vs ARCC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 23 | May 26 | Return |
|---|---|---|---|
| MDB Capital Holding… (MDBH) | 100 | 31.3 | -68.7% |
| TriplePoint Venture… (TPVG) | 100 | 57.3 | -42.7% |
| Hercules Capital, I… (HTGC) | 100 | 99.9 | -0.1% |
| Gladstone Investmen… (GAIN) | 100 | 129.6 | +29.6% |
| Ares Capital Corpor… (ARCC) | 100 | 97.4 | -2.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MDBH vs TPVG vs HTGC vs GAIN vs ARCC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MDBH is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.45, Low D/E 1.0%, current ratio 19.80x
- Lower P/E (1.4x vs 8.4x)
- Beta 0.45 vs TPVG's 0.83, lower leverage
TPVG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.83, yield 17.1%
- Rev growth 36.6%, EPS growth 48.8%
- 36.6% NII/revenue growth vs MDBH's -47.5%
- Efficiency ratio 0.1% vs MDBH's 4.9% (lower = leaner)
HTGC is the clearest fit if your priority is bank quality.
- NIM 9.1% vs MDBH's 1.5%
GAIN ranks third and is worth considering specifically for long-term compounding and defensive.
- 319.3% 10Y total return vs HTGC's 171.6%
- Beta 0.53, yield 10.0%, current ratio 3.69x
- +30.8% vs MDBH's -19.4%
ARCC is the clearest fit if your priority is valuation efficiency.
- PEG 0.96 vs TPVG's 6.41
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs MDBH's -47.5% | |
| Value | Lower P/E (1.4x vs 8.4x) | |
| Quality / Margins | Efficiency ratio 0.1% vs MDBH's 4.9% (lower = leaner) | |
| Stability / Safety | Beta 0.45 vs TPVG's 0.83, lower leverage | |
| Dividends | 17.1% yield, vs GAIN's 10.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +30.8% vs MDBH's -19.4% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs MDBH's 4.9% |
MDBH vs TPVG vs HTGC vs GAIN vs ARCC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAIN leads in 2 of 6 categories
TPVG leads 1 • MDBH leads 1 • HTGC leads 0 • ARCC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 1416.3x MDBH's $2M. Profitability is closely matched — net margins range from 5.3% (MDBH) to 41.3% (ARCC).
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2M | $97M | $547M | $90M | $3.1B |
| EBITDAEarnings before interest/tax | -$24M | -$22M | $381M | $58M | $2.0B |
| Net IncomeAfter-tax profit | $11M | -$12M | $289M | $130M | $1.1B |
| Free Cash FlowCash after capex | -$4M | $35M | -$352M | -$82M | $1.1B |
| Gross MarginGross profit ÷ Revenue | -8.0% | +83.5% | +87.2% | +68.6% | +75.7% |
| Operating MarginEBIT ÷ Revenue | -12.9% | +77.9% | +66.7% | +72.7% | +69.7% |
| Net MarginNet income ÷ Revenue | +5.3% | +50.6% | +62.1% | +72.7% | +41.3% |
| FCF MarginFCF ÷ Revenue | -3.8% | -58.7% | -77.8% | +126.8% | +36.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +43.4% | -2.3% | -20.7% | +58.1% | -63.9% |
Valuation Metrics
TPVG leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 1.4x trailing earnings, MDBH trades at a 87% valuation discount to ARCC's 10.2x P/E. Adjusting for growth (PEG ratio), ARCC offers better value at 0.99x vs TPVG's 4.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $18M | $243M | $3.1B | $657M | $13.6B |
| Enterprise ValueMkt cap + debt − cash | -$2M | $691M | $5.3B | $1.1B | $28.7B |
| Trailing P/EPrice ÷ TTM EPS | 1.36x | 4.91x | 8.86x | 9.28x | 10.19x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.50x | 8.41x | 40.66x | 9.92x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.84x | — | — | 0.99x |
| EV / EBITDAEnterprise value multiple | — | 9.13x | 14.54x | 16.82x | 13.09x |
| Price / SalesMarket cap ÷ Revenue | 8.07x | 2.50x | 5.61x | 7.31x | 4.33x |
| Price / BookPrice ÷ Book value/share | 0.23x | 0.68x | 1.44x | 1.22x | 0.93x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 5.77x | 11.92x |
Profitability & Efficiency
MDBH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-3 for TPVG. MDBH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), MDBH scores 5/9 vs ARCC's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.2% | -3.4% | +13.2% | +21.9% | +8.1% |
| ROA (TTM)Return on assets | +18.6% | -1.5% | +6.4% | +10.5% | +3.8% |
| ROICReturn on invested capital | -38.9% | +7.2% | +6.6% | +5.3% | +5.7% |
| ROCEReturn on capital employed | -51.8% | +9.4% | +8.8% | +6.8% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 1.33x | 1.04x | 0.91x | 1.12x |
| Net DebtTotal debt minus cash | -$20M | $449M | $2.2B | $441M | $15.1B |
| Cash & Equiv.Liquid assets | $20M | $20M | $57M | $14M | $924M |
| Total DebtShort + long-term debt | $711,503 | $469M | $2.3B | $456M | $16.0B |
| Interest CoverageEBIT ÷ Interest expense | -399.73x | -1.02x | 4.34x | 1.58x | 2.98x |
Total Returns (Dividends Reinvested)
GAIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $2,868 for MDBH. Over the past 12 months, GAIN leads with a +30.8% total return vs MDBH's -19.4%. The 3-year compound annual growth rate (CAGR) favors HTGC at 17.9% vs MDBH's -34.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | -6.3% | -10.6% | +20.7% | -4.9% |
| 1-Year ReturnPast 12 months | -19.4% | +19.3% | +6.6% | +30.8% | +0.4% |
| 3-Year ReturnCumulative with dividends | -71.3% | -3.4% | +63.9% | +56.5% | +34.2% |
| 5-Year ReturnCumulative with dividends | -71.3% | -13.5% | +46.8% | +72.0% | +47.0% |
| 10-Year ReturnCumulative with dividends | -71.3% | +93.3% | +171.6% | +319.3% | +139.2% |
| CAGR (3Y)Annualised 3-year return | -34.1% | -1.2% | +17.9% | +16.1% | +10.3% |
Risk & Volatility
Evenly matched — MDBH and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MDBH is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than TPVG's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 96.3% from its 52-week high vs MDBH's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 0.83x | 0.69x | 0.53x | 0.77x |
| 52-Week HighHighest price in past year | $5.50 | $7.53 | $19.67 | $17.14 | $23.42 |
| 52-Week LowLowest price in past year | $2.75 | $4.48 | $13.70 | $13.11 | $17.40 |
| % of 52W HighCurrent price vs 52-week peak | +65.2% | +79.5% | +83.4% | +96.3% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 65.5 | 58.3 | 64.7 | 69.9 | 56.7 |
| Avg Volume (50D)Average daily shares traded | 6K | 504K | 2.5M | 371K | 7.5M |
Analyst Outlook
Evenly matched — MDBH and TPVG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TPVG as "Hold", HTGC as "Buy", GAIN as "Hold", ARCC as "Buy". Consensus price targets imply 49.4% upside for TPVG (target: $9) vs -9.1% for GAIN (target: $15). For income investors, TPVG offers the higher dividend yield at 17.11% vs ARCC's 2.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $8.95 | $18.92 | $15.00 | $21.88 |
| # AnalystsCovering analysts | — | 12 | 31 | 7 | 32 |
| Dividend YieldAnnual dividend ÷ price | — | +17.1% | +8.6% | +10.0% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $1.02 | $1.42 | $1.66 | $0.38 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | 0.0% | 0.0% |
GAIN leads in 2 of 6 categories (Income & Cash Flow, Total Returns). TPVG leads in 1 (Valuation Metrics). 2 tied.
MDBH vs TPVG vs HTGC vs GAIN vs ARCC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MDBH or TPVG or HTGC or GAIN or ARCC a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -47. 5% for MDB Capital Holdings, LLC Class A common (MDBH). MDB Capital Holdings, LLC Class A common (MDBH) offers the better valuation at 1. 4x trailing P/E, making it the more compelling value choice. Analysts rate Hercules Capital, Inc. (HTGC) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MDBH or TPVG or HTGC or GAIN or ARCC?
On trailing P/E, MDB Capital Holdings, LLC Class A common (MDBH) is the cheapest at 1.
4x versus Ares Capital Corporation at 10. 2x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ares Capital Corporation wins at 0. 96x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MDBH or TPVG or HTGC or GAIN or ARCC?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to -71. 3% for MDB Capital Holdings, LLC Class A common (MDBH). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus MDBH's -71. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MDBH or TPVG or HTGC or GAIN or ARCC?
By beta (market sensitivity over 5 years), MDB Capital Holdings, LLC Class A common (MDBH) is the lower-risk stock at 0.
45β versus TriplePoint Venture Growth BDC Corp. 's 0. 83β — meaning TPVG is approximately 85% more volatile than MDBH relative to the S&P 500. On balance sheet safety, MDB Capital Holdings, LLC Class A common (MDBH) carries a lower debt/equity ratio of 1% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — MDBH or TPVG or HTGC or GAIN or ARCC?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -47. 5% for MDB Capital Holdings, LLC Class A common (MDBH). On earnings-per-share growth, the picture is similar: MDB Capital Holdings, LLC Class A common grew EPS 407. 0% year-over-year, compared to -27. 9% for Gladstone Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MDBH or TPVG or HTGC or GAIN or ARCC?
MDB Capital Holdings, LLC Class A common (MDBH) is the more profitable company, earning 526.
5% net margin versus 41. 3% for Ares Capital Corporation — meaning it keeps 526. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -1289. 4% for MDBH. At the gross margin level — before operating expenses — HTGC leads at 87. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MDBH or TPVG or HTGC or GAIN or ARCC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Ares Capital Corporation (ARCC) is the more undervalued stock at a PEG of 0. 96x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 5x forward P/E versus 40. 7x for Gladstone Investment Corporation — 34. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 49. 4% to $8. 95.
08Which pays a better dividend — MDBH or TPVG or HTGC or GAIN or ARCC?
In this comparison, TPVG (17.
1% yield), GAIN (10. 0% yield), HTGC (8. 6% yield), ARCC (2. 0% yield) pay a dividend. MDBH does not pay a meaningful dividend and should not be held primarily for income.
09Is MDBH or TPVG or HTGC or GAIN or ARCC better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, MDBH: -71. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MDBH and TPVG and HTGC and GAIN and ARCC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MDBH is a small-cap deep-value stock; TPVG is a small-cap high-growth stock; HTGC is a small-cap high-growth stock; GAIN is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock. TPVG, HTGC, GAIN, ARCC pay a dividend while MDBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.